2-Hydroxypropyl-beta-cyclodextrin: Clinical Trials

6 trials of 2-Hydroxypropyl-beta-cyclodextrin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated, 1 unknown. 6 Phase 2, 3 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 3, Terminated 2, Unknown 1
Phase 33Terminated 2, Completed 1
Phase 12Completed 2

Follow 2-Hydroxypropyl-beta-cyclodextrin: new trials by email Literature Review of 2-Hydroxypropyl-beta-cyclodextrin trials Research Report on 2-Hydroxypropyl-beta-cyclodextrin

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease
Hydroxypropyl Beta Cyclodextrin, Placebo - Alzheimer's Disease
Phase 2UnknownCyclo Therapeutics, Inc.902022-09-232023-04-25
Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1
VTS-270 - Niemann-Pick Disease, Type C
Phase 2 / Phase 3TerminatedMandos LLC22019-12-022023-12-26
Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C
VTS-270 - Niemann-Pick Disease, Type C
Phase 1 / Phase 2CompletedWashington University School of Medicine42019-02-222026-01-05
Safety and Efficacy of Intravenous Trappsol Cyclo (HPBCD) in Niemann-Pick Type C Patients
Hydroxypropyl-beta-cyclodextrin - Niemann-Pick Disease, Type C1
Phase 1 / Phase 2CompletedCyclo Therapeutics, Inc.122017-03-202021-08-10
Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease
Adrabetadex - Niemann-Pick Disease, Type C
Phase 2 / Phase 3TerminatedMandos LLC662015-12-232023-08-29
VTS-270 to Treat Niemann-Pick Type C1 (NPC1) Disease
Parts A/B: Adrabetadex, Parts A/B: Sham Control - Niemann-Pick Disease, Type C
Phase 2 / Phase 3CompletedMandos LLC562015-10-012023-02-22

Conditions studied

Niemann-Pick Disease, Type C (5)  ·  Cognitive Dysfunction (2)  ·  Deglutition Disorders (2)  ·  Disease (2)  ·  Mobility Limitation (2)  ·  Alzheimer Disease (1)

Sponsors

Mandos LLC (3)  ·  Cyclo Therapeutics, Inc. (2)  ·  Washington University School of Medicine (1)

Countries

United States (4)  ·  United Kingdom (3)  ·  Australia (2)  ·  France (2)  ·  Germany (2)  ·  New Zealand (2)  ·  Singapore (2)  ·  Turkey (Türkiye) (2)  ·  Costa Rica (1)  ·  Israel (1)  ·  Spain (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Karen Mullen, MD (1)  ·  Patricia I Dickson, MD (1)  ·  Reena Sharma, MB BS (1)

Results publications

PMID 37670901, PMID 40525490

NIH funding

2015 (2), U01HD090845 (1)